{"organizations": [], "uuid": "e97873110e2a0a63d57217d79a6474f24e899bf9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-sarepta-therapeutics-reports-q4-no/brief-sarepta-therapeutics-reports-q4-non-gaap-loss-per-share-0-28-idUSASB0C8FV", "country": "US", "domain_rank": 408, "title": "BRIEF-Sarepta Therapeutics Reports Q4 Non-GAAP Loss Per Share $0.28", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.855, "site_type": "news", "published": "2018-03-02T05:07:00.000+02:00", "replies_count": 0, "uuid": "e97873110e2a0a63d57217d79a6474f24e899bf9"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sarepta-therapeutics-reports-q4-no/brief-sarepta-therapeutics-reports-q4-non-gaap-loss-per-share-0-28-idUSASB0C8FV", "ord_in_thread": 0, "title": "BRIEF-Sarepta Therapeutics Reports Q4 Non-GAAP Loss Per Share $0.28", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sarepta therapeutics inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 1 (Reuters) - Sarepta Therapeutics Inc:\n* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER 2017 AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS\n* Q4 NON-GAAP LOSS PER SHARE $0.28\n* Q4 GAAP LOSS PER SHARE $0.37 * Q4 REVENUE $57.3 MILLION * Q4 EARNINGS PER SHARE VIEW $-0.32, REVENUE VIEW $56.5 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-02T05:07:00.000+02:00", "crawled": "2018-03-01T23:23:16.003+02:00", "highlightTitle": ""}